Atractylenolide II combined with Interferon-γ synergistically ameliorates colorectal cancer progression in vivo and in vitro by blocking the NF-kB p65/PD-L1 pathway.
Koidz herbal medicine combined with IFN-γ inhibits CRC progression by regulating NF-kB p65/PD-L1 pathway. Effective against CRC cells and xenograft tumors in mice, shows potential for tumor immunotherapy.
- Wu Y et al (2024).
- J Cancer.
- DOI:
- 10.7150/jca.96647
- PubMed:
- 38947390